Drug Delivery Stocks List

Drug Delivery Stocks Recent News

Date Stock Title
Mar 28 WST Why Is Henry Schein (HSIC) Down 1.8% Since Last Earnings Report?
Mar 28 BDX Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Mar 27 DRRX DURECT Corporation (DRRX) Q4 2023 Earnings Call Transcript
Mar 27 DRRX Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates
Mar 27 MDT Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst
Mar 27 MDT Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
Mar 27 DRRX DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Mar 27 BIOR BIOR: Negotiations Accelerating
Mar 27 BIOR Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2023 Earnings Call Transcript
Mar 27 MDT Medtronic wins FDA OK for heart valve implant
Mar 27 MDT Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
Mar 27 MDT Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now
Mar 27 HTGC Fitch affirms Hercules Capital at 'BBB-'
Mar 27 BDX New Survey Reveals Patients Receive Too Many Needlesticks
Mar 27 BIOR Q4 2023 Biora Therapeutics Inc Earnings Call
Mar 27 HTGC Hercules Capital Receives BBB- Affirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
Mar 27 DRRX Earnings Scheduled For March 27, 2024
Mar 27 MDT 3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
Mar 27 HTGC Q4 2023 bluebird bio Inc Earnings Call
Mar 26 BIOR Biora Therapeutics, Inc. (BIOR) Q4 2023 Earnings Call Transcript
Drug Delivery

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.Drug delivery technologies modify drug release profile, absorption, distribution and elimination for the benefit of improving product efficacy and safety, as well as patient convenience and compliance. Drug release is from: diffusion, degradation, swelling, and affinity-based mechanisms. Some of the common routes of administration include the enteral (gastrointestinal tract), parenteral (via injections), inhalation, transdermal, topical and oral routes. . Many medications such as peptide and protein, antibody, vaccine and gene based drugs, in general may not be delivered using these routes because they might be susceptible to enzymatic degradation or can not be absorbed into the systemic circulation efficiently due to molecular size and charge issues to be therapeutically effective. For this reason many protein and peptide drugs have to be delivered by injection or a nanoneedle array.
For example, many immunizations are based on the delivery of protein drugs and are often done by injection.
Current efforts in the area of drug delivery include the development of targeted delivery in which the drug is only active in the target area of the body (for example, in cancerous tissues), sustained release formulations in which the drug is released over a period of time in a controlled manner from a formulation, and methods to increase survival of peroral agents which must pass through the stomach's acidic environment. In order to achieve efficient targeted delivery, the designed system must avoid the host's defense mechanisms and circulate to its intended site of action. Types of sustained release formulations include liposomes, drug loaded biodegradable microspheres and drug polymer conjugates. Survival of agents as they pass through the stomach typically is an issue for agents which cannot be encased in a solid tablet; one research area has been around the utilization of lipid isolates from the acid-resistant archaea Sulfolobus islandicus, which confers on the order of 10% survival of liposome-encapsulated agents.

Browse All Tags